NCT06180720View on ClinicalTrials.gov

Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

January 4, 2024

Study Completion Date

November 20, 2024

Conditions
Healthy
Interventions
DRUG

Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)

Specification:Levodopa 100mg, Carbidopa 25mg, Entacapone 200mg(Abbreviation: 100mg/25mg/200mg). Produced and supplied by Qilu Pharmaceutical Co.

DRUG

Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)

Specification:Levodopa 100mg, Carbidopa 25mg, Entacapone 200mg(Abbreviation: 100mg/25mg/200mg). Supplied by Qilu Pharmaceutical Co.

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER